GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Astrana Health Inc (NAS:ASTH) » Definitions » Altman Z-Score

Astrana Health (Astrana Health) Altman Z-Score : 4.44 (As of Apr. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Astrana Health Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 4.44 is strong.

Astrana Health has a Altman Z-Score of 4.44, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Astrana Health's Altman Z-Score or its related term are showing as below:

ASTH' s Altman Z-Score Range Over the Past 10 Years
Min: -4.24   Med: 2.31   Max: 7.35
Current: 4.44

During the past 13 years, Astrana Health's highest Altman Z-Score was 7.35. The lowest was -4.24. And the median was 2.31.


Astrana Health Altman Z-Score Historical Data

The historical data trend for Astrana Health's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astrana Health Altman Z-Score Chart

Astrana Health Annual Data
Trend Jan14 Mar15 Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.42 2.19 7.35 4.15 4.60

Astrana Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.15 4.65 4.23 4.08 4.60

Competitive Comparison of Astrana Health's Altman Z-Score

For the Medical Care Facilities subindustry, Astrana Health's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astrana Health's Altman Z-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Astrana Health's Altman Z-Score falls into.



Astrana Health Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Astrana Health's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.2602+1.4*0.2605+3.3*0.1135+0.6*3.179+1.0*1.4857
=4.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was $933 Mil.
Total Current Assets was $462 Mil.
Total Current Liabilities was $219 Mil.
Retained Earnings was $243 Mil.
Pre-Tax Income was 0.924 + 38.015 + 31.491 + 19.409 = $90 Mil.
Interest Expense was -5.422 + -3.779 + -3.632 + -3.269 = $-16 Mil.
Revenue was 353.036 + 348.173 + 348.209 + 337.244 = $1,387 Mil.
Market Cap (Today) was $1,661 Mil.
Total Liabilities was $523 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(461.507 - 218.674)/933.361
=0.2602

X2=Retained Earnings/Total Assets
=243.134/933.361
=0.2605

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(89.839 - -16.102)/933.361
=0.1135

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=1661.330/522.593
=3.179

X5=Revenue/Total Assets
=1386.662/933.361
=1.4857

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Astrana Health has a Altman Z-Score of 4.44 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Astrana Health  (NAS:ASTH) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Astrana Health Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Astrana Health's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Astrana Health (Astrana Health) Business Description

Traded in Other Exchanges
Address
1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Apollo Medical Holdings Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care in a cost-effective manner. It is focused on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
Executives
Chandan Basho officer: See Remarks 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
John Vong officer: SVP-Chief Accounting Officer 4288 BIRCHWOOD AVENUE, SEAL BEACH CA 90740
Linda Marsh director 100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801
Allied Physicians Of California, A Profession Medical Corp 10 percent owner 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Weili Dai, director 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
J. Lorraine Estradas director 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
David Schmidt director 700 N. BRAND BLVD, SUITE 220, GLENDALE CA 91203
Albert Waichow Young officer: Chief Administrative Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Adrian Vazquez officer: Chief Medical Officer C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Thomas S. Lam director, officer: President and Co-CEO 1668 GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Kenneth T. Sim director, officer: Executive Chairman and Co-CEO 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Brandon Sim director, officer: See Remarks C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801
Eric Chin officer: Chief Financial Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Michael F. Eng director 712 BATAAN PLACE, MONTEREY PARK CA 91755
Hing Ang officer: Chief Operating Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801